Zdrowie i gospodarka · 01/02/2023

FDA Clears LOTENSIN Tablets for Continued Approval

The US Food and Drug Administration (FDA) has determined that the 5mg LOTENSIN (benazepril hydrochloride) tablets were not withdrawn from sale due to safety or effectiveness concerns. This decision allows the FDA to continue approving Abbreviated New Drug Applications (ANDAs) for the product as long as they meet regulatory requirements.